CTXR Stock Price
Citius Pharmaceuticals, Inc.
CTXR stock price is $0.47 (-2.31% on the day), giving Citius Pharmaceuticals, Inc. a market cap of $12.77M. Below are the price chart, the MarketXLS Rank, the company profile and the latest news.
CTXR Stock Overview
- Price
- $0.47
- Previous close
- $0.48
- Open
- $0.46
- Market cap
- $12.77M
- P/E ratio
- -0.3
- 52-week range
- $0.47 - $2.19
- 1-year price target
- $4.00
- Sector
- Healthcare
- Industry
- Biotechnology
- Exchange
- NSC
- MarketXLS Rank
- 30
About Citius Pharmaceuticals, Inc.
Citius Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of critical care products. Its LYMPHIR, an FDA approved product, is a targeted immunotherapy for the treatment of cutaneous T-cell lymphoma. The company's late-stage pipeline includes Mino-Lok, an antibiotic lock solution to salvage catheters in patients with catheter-related bloodstream infections; and CITI-002 (Halo-Lido), a topical formulation for the relief of hemorrhoids. The Pivotal Phase 3 Trial for Mino-Lok and a Phase 2b trial for Halo-Lido completed. Citius Pharmaceuticals, Inc. was founded in 2007 and is headquartered in Cranford, New Jersey.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CTXR | $0.47 | -2.3% | 233.51K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Citius Pharmaceuticals, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW